GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $10,727,000 | – | 62,100 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copernicus Capital Management, LLC | 52,488 | $5,110,000 | 4.87% |
| GREAT POINT PARTNERS LLC | 520,232 | $50,645,000 | 4.56% |
| Integral Health Asset Management, LLC | 65,000 | $6,328,000 | 1.94% |
| CLOUGH CAPITAL PARTNERS L P | 190,716 | $18,566,000 | 1.34% |
| Parkman Healthcare Partners LLC | 50,000 | $4,868,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 375,344 | $36,540,000 | 1.16% |
| Redwood Investments, LLC | 124,094 | $12,081,000 | 1.02% |
| Eventide Asset Management | 436,000 | $42,445,000 | 0.83% |
| Bellevue Group AG | 562,943 | $54,803,000 | 0.76% |
| ROOSEVELT INVESTMENT GROUP LLC | 95,499 | $9,297,000 | 0.75% |